Skip to search formSkip to main contentSkip to account menu

RU 23908

Known as: RU-23908 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

nilutamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Androgen regulation of prolactin‐receptor gene expression in MCF‐7 and MDA‐MB‐453 human breast cancer cells
Lactogenic hormones which bind to the PRLR are likely to be growth‐stimulatory in human breast‐cancer cells. Oestrogen and… 
1990
1990
Evidence that testosterone modulates in vivo the adenylate cyclase activity in fat cells.
In male hamster fat cell membranes, the alpha 2-adrenoreceptor-mediated inhibitory response of adenylate cyclase was almost… 
1989
1989
Androgen modulation of prostate cancer cell androgen receptor content is cell line specific
1988
1988
Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
The effects of the s.c. administration of a depot formulation of the luteinizing hormone-releasing hormone (LHRH) analogue… 
1988
1988
Effects of castration and antiandrogens (RU 23908 and cyproterone acetate) on glandulain activity and on the secretory epithelium of the rat submandibular gland.
1. The influence of hormones on the submandibular gland of rodents has attracted more attention since the observation of the… 
1983
1983
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist.
Treatment with an LHRH agonist (HOE-766) alone causes an almost complete blockage of testicular testosterone formation in rat and… 
Review
1983
Review
1983
[New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
Following the studies of Huggins and colleagues in 1941, the hormonal treatment of prostatic cancer has been aimed at… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)